Certified by Founder Lodge
Delfi Diagnostics
United States - Baltimore, Maryland
START UP
1 Disclosed Funding Rounds $225,000,000
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
DELFI uses artificial intelligence and whole genome sequencing to sensitively detect unique patterns of DNA fragmentation in the blood of patients with cancer.
Date | Round | Raised | Participating Investors |
---|---|---|---|
July, 18 ,2022 | Series B | $225,000,000 |